Latest National Cancer Institute Stories
RadioMedix, Inc., a Houston-based biotechnology company and Viewpoint Molecular Targeting LLC of Iowa City were awarded a grant by the Small Business Innovation Research (SBIR) program from the
SAN DIEGO, Oct.
NuvOx Pharma, a biotechnology company based in Tucson, Arizona, has received a $1Million grant from the National Cancer Institute (NCI) “Nanoparticle-based Sensitizer for Radiation Therapy of
DIA in cooperation with SureClinical will host a complimentary webinar "How New Electronic Trial Master File (eTMF) Data Standards Can Enhance Clinical Trial Efficiency and Quality"
Program Funded by the National Cancer Institute (NCI) CHARLOTTESVILLE, Va., Oct.
SureClinical, National Cancer Institute, ACT Oncology and CareLex to discuss how the draft OASIS eTMF Standard Can Enhance Clinical Trial Efficiency and Quality Rancho
- Awarded phase II STTR grant of approximately $1.1 million from NIH to develop tumor activated prodrugs BOSTON, Sept.
Treatment designed to reduce pain and inflammation associated with radiation therapy to the lower bowel. Claremont, CA (PRWEB) September 27, 2014 Synedgen
Collaborative efforts with leading cancer centers to provide clinical test is supported CAMBRIDGE, Mass., Sept.
- To give a box on the ear to.